GlycanAge competitors & alternatives

InocrasHealthcareUnited States

60% match

Similar healthcare company

Inocras Inc. is a bioinformatics-led biotechnology company headquartered in San Diego, California. The firm utilizes whole genome data and proprietary artificial intelligence analytics to deliver curated genomic care.

Cyted HealthHealthcareUnited Kingdom

60% matchPrivate

Similar healthcare company

Cyted Health delivers a diagnostic platform that combines minimally invasive cell collection with high-resolution molecular analysis. This platform is designed to detect early biological markers.

Healthtech

Asparia Glycomics is a biotechnology company based in San Sebastián, Spain, specializing in glycoscience, precision analytics, and glycotechnology services.

OXFORD BIODYNAMICS PLCOBD · BiotechOxford, United Kingdom

66% matchPublic

Biotech

Oxford BioDynamics Plc operates as a biotechnology firm that specializes in identifying and advancing biomarkers, primarily for the pharmaceutical and biotechnology sectors across global markets, including the United States. Its flagship offering is EpiSwitch, an exclusive technological platform employed for discovering, assessing, validating, and tracking epigenetic biomarkers, specifically referred to as chromosome conformation signatures. These are crucial for developing medical diagnostic kits, predicting disease onset, aiding in diagnosis, and informing therapeutic strategies. The company's key products encompass the EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic tool for forecasting patient responses to checkpoint inhibitor immunotherapy; the EpiSwitch CST (Covid Severity Test), a sophisticated blood test designed to predict the severity of COVID-19 in adults; and the EpiSwitch Explorer Array Kit, which enables high-resolution 3D genome analysis and novel biomarker discovery. Established in 2007, Oxford BioDynamics Plc maintains its headquarters in Oxford, United Kingdom.

Infinity Bio, Inc.Healthcare Technology SystemsUnited States

65% match

Healthcare Technology Systems

Infinity Bio, Inc. is a biotechnology research company that provides detailed insights into the immune system utilizing its proprietary antibody reactome profiling platform.

Nightingale Health PlcNHLTY · BiotechUnited States

64% matchPublic

Biotech

Nightingale Health Plc provides advanced health check and remote health check products designed for the healthcare, insurance, government, and consumer health sectors. The company also offers proprietary 'omics technology and preventive screening solutions to support medical research and disease risk detection.

Edifice Health, Inc.DiagnosticsUnited States

64% matchPrivate

Diagnostics

Edifice Health, Inc., formerly known as IUVE, Inc., is a Silicon Valley-based emerging company headquartered in San Mateo, California. The company specializes in immunological health, focusing on the detection and measurement of systemic chronic inflammation.

Adaptive Biotechnologies Corp.ADPT · BiotechnologySeattle, United States

64% matchPublicAI 12/100 ▲Green 0/100 ▼

Biotechnology

Adaptive Biotechnologies Corp. is a biotechnology company headquartered in Seattle, Washington, United States. The firm focuses on decoding and analyzing the human immune system to address various diseases.

InsideTrackerHealth & WellnessUnited States

64% match

Health & Wellness

InsideTracker is an evidence-based, AI-driven health platform founded in 2009 by experts from MIT and Tufts, headquartered in Cambridge, Massachusetts, focusing on aging, genetics, and biometric data.

IMU BiosciencesBiotechUnited Kingdom

63% match

Biotech

IMU Biosciences is headquartered in London, United Kingdom, and operates in the biotechnology sector. The company develops data platforms and immunological profiling technologies supported by a growing scientific team.

GENINCODE PLCBiotechOxford, United Kingdom

63% match

Biotech

GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.

Microba Life SciencesMAP · Biotechnology / Health TechBrisbane, Australia

63% matchPublic

Biotechnology / Health Tech

Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science. Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers. Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.